Epilepsy Today Latest News
DWP urged to be “bolder” in ambitions to reduce disability employment gap
The Work and Pensions Committee has called on the government’s Department for Work and Pensions (DWP) to be “bolder in its ambitions” to support disabled people to find and stay in work.
UK government rejects call for redress schemes for people affected by valproate scandal
The government has rejected the recommendation to set up redress schemes for valproate, Primodos and pelvic mesh, in its full response to the Independent Medicines and Medical Devices Safety (IMMDS) review.
Three in four children who should be considered for epilepsy surgery not referred, Epilepsy12 report shows
Findings from the latest Epilepsy12 report reveal issues among children’s epilepsy services in England and Wales with referrals, information provision and school care plans.
Three in four children who should be considered for epilepsy surgery not referred, Epilepsy12 report shows
Findings from the latest Epilepsy12 report reveal issues among children’s epilepsy services in England and Wales with referrals, information provision and school care plans.
Welfare survey
In 2020, there was marked improvement in the outcomes of Personal Independence Payment (PIP) applications for people with epilepsy.
Despite this improvement, there is still much more to do, and there are still people with epilepsy who should be in receipt of PIP being refused.
Concerning lack of response from government to sodium valproate recommendations on Cumberlege report anniversary
Epilepsy Action has expressed concern over the lack of response from the government on specific recommendations made by the Cumberlege report in July 2020 on sodium valproate.
COVID-19 booster vaccine may be offered from September to most vulnerable
A booster COVID-19 vaccine may be offered from September 2021 to the most vulnerable people in the UK to ensure protection continues over the winter season.
NHS to send information to women and girls in England taking sodium valproate
The NHS will be sending a letter with information to 20,000 women and girls in England who have a prescription of sodium valproate, 